Polyclonal antithymocyte antibody

This page covers all Polyclonal antithymocyte antibody drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting T-cell surface antigens (CD2, CD3, CD4, CD8, and other T-cell markers), Multiple T-cell surface antigens (CD2, CD3, CD4, CD8, HLA-DR), T-cell surface antigens (CD2, CD3, CD4, CD8, HLA-DR).

Targets

T-cell surface antigens (CD2, CD3, CD4, CD8, and other T-cell markers) · Multiple T-cell surface antigens (CD2, CD3, CD4, CD8, HLA-DR) · T-cell surface antigens (CD2, CD3, CD4, CD8, HLA-DR) · T lymphocyte surface antigens (CD2, CD3, CD4, CD8, HLA-DR)

Marketed (4)

• ATG · ITB-Med LLC · Immunology
  ATG (Antithymocyte Globulin) is a polyclonal antibody that depletes T lymphocytes by binding to T-cell antigens and triggering their destruction.
• Antithymocyte globulin · National Institute of Allergy and Infectious Diseases (NIAID) · Immunology
  Antithymocyte globulin (ATG) is a polyclonal antibody preparation that depletes T lymphocytes by binding to and eliminating T cells in the circulation and lymphoid tissues.
• Anti-Thymocyte Globulins treatment · Nantes University Hospital · Immunology
  Anti-thymocyte globulin (ATG) depletes T lymphocytes by binding to T-cell antigens and triggering their destruction, thereby suppressing the adaptive immune response.
• rabbit anti-thymocyte globulin - 4 doses · University of Nebraska · Immunology
  Rabbit anti-thymocyte globulin (rATG) depletes T lymphocytes by binding to and eliminating thymus-derived T cells, suppressing the adaptive immune response.